Findings from a new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry May 28 may lead to a new treatment against Toxoplasma gondii, the parasite that causes toxoplasmosis.
Jul 1, 2022
0
1174
In a bit of "reverse engineering" research using brain tissues from five people who died with Alzheimer's disease, Johns Hopkins Medicine researchers say they discovered that a special sugar molecule could play a key role ...
May 27, 2022
0
241
New computational simulations of the behavior of SARS-CoV-1 and SARS-CoV-2 spike proteins prior to fusion with human cell receptors show that SARS-CoV-2, the virus that causes COVID-19, is more stable and slower-changing ...
Mar 30, 2022
0
42
A 'waste collection' tidiesup our cells. If something does not go according to plan, serious diseasessuch as Alzheimer's or Parkinson's may develop. Molecular biologist Sascha Martens from the University of Vienna together ...
Feb 17, 2022
0
8
New research shows for the first time why the antiviral drug remdesivir works against some viruses but not others—a finding that improves our understanding of how antiviral drugs interact with viruses at a molecular level, ...
Jan 13, 2022
0
19
When an individual suffers from cancer, the process of programmed cell death called apoptosis does not occur normally, permitting abnormal cells to thrive.
Jan 11, 2022
0
69
Researchers at the Indian Institute of Science (IISc) and their collaborators have identified a key role played by hydrogen sulfide (H2S) gas in suppressing the human immunodeficiency virus (HIV). Increased H2S was found ...
Dec 7, 2021
0
46
Drug hunters hoping to prevent or delay the onset of Alzheimer's disease take note—a new mouse model developed at RIKEN offers a powerful platform for evaluating potential therapies designed to combat the neurodegenerative ...
Dec 1, 2021
0
28
Immunotherapy, which harnesses the power of the body's immune system to fight disease, is gaining huge traction in treating cancer. Chief among cancer immunotherapies is a treatment known as CAR-T, or chimeric antigen receptor ...
Oct 4, 2021
0
85
University of Utah Health scientists have identified a molecule that slows cells' production of alpha-synuclein, a protein that forms toxic aggregates in the brains of people with Parkinson's disease. Its discovery points ...
Sep 21, 2021
0
67
